Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells

FEBS Letters

Volumn 581, Issue 25, 2007, Pages 4927-4931

  Opitz, Christiane A ^a   Rimmerman, Neta ^b   Zhang, Yanmin ^a   Mead, Laura E ^c   Yoder, Mervin C ^c   Ingram, David A ^c   Walker, J Michael ^b   Rehman, Jalees ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endocannabinoid; Endothelial progenitor cell; Endothelium; Endothelium derived factor; Inflammation

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL MATURATION; COLONY FORMING UNIT; CONTROLLED STUDY; ENDOTHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; STEM CELL; TANDEM MASS SPECTROMETRY;

ARACHIDONIC ACIDS; ENDOCANNABINOIDS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLYCERIDES; HUMANS; POLYUNSATURATED ALKAMIDES; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34948860151     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.09.032     Document Type: Article

References (24)

1. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Barber C.L., and Iruela-Arispe M.L. The ever-elusive endothelial progenitor cell: identities, functions and clinical implications. Pediatr. Res. 59 (2006) 26R-32R
3. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood endothelial progenitor cells are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
4. Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., and Simari R.D. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93 (2003) 1023-1025
5. Ingram D.A., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104 (2004) 2752-2760
6. Lin Y., Weisdorf D.J., Solovey A., and Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105 (2000) 71-77
7. He T., Peterson T.E., and Katusic Z.S. Paracrine mitogenic effect of human endothelial progenitor cells: role of interleukin-8. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H968-H972
8. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., and Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell Cardiol. 39 (2005) 733-742
9. Yoon C.H., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112 (2005) 1618-1627
10. Wagner J.A., Hu K., Bauersachs J., Karcher J., Wiesler M., Goparaju S.K., Kunos G., and Ertl G. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J. Am. Coll. Cardiol. 38 (2001) 2048-2054
11. Wagner J.A., Varga K., Ellis E.F., Rzigalinski B.A., Martin B.R., and Kunos G. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390 (1997) 518-521
12. Deutsch D.G., et al. Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest. 100 (1997) 1538-1546
13. Underdown N.J., Hiley C.R., and Ford W.R. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Br. J. Pharmacol. 146 (2005) 809-816
14. Bradshaw H.B., Rimmerman N., Krey J.F., and Walker J.M. Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R349-R358
15. Ingram D.A., Caplice N.M., and Yoder M.C. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 106 (2005) 1525-1531
16. Ingram D.A., Mead L.E., Moore D.B., Woodard W., Fenoglio A., and Yoder M.C. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105 (2005) 2783-2786
17. Walter L., and Stella N. Cannabinoids and neuroinflammation. Br. J. Pharmacol. 141 (2004) 775-785
18. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., Fuchs S., and Epstein S.E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109 (2004) 1543-1549
19. Klein T.W., Newton C., Larsen K., Lu L., Perkins I., Nong L., and Friedman H. The cannabinoid system and immune modulation. J. Leukocyte Biol. 74 (2003) 486-496
20. Witting A., et al. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc. Natl. Acad. Sci. USA 103 (2006) 6362-6367
21. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
22. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) 110-112
23. Cybulsky M.I., et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107 (2001) 1255-1262
24. Steffens S., et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 434 (2005) 782-786